Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia

In Western countries, clinical trials on prostate cancer screening demonstrated a limited benefit for patient survival. In the Asia-Pacific region, including Japan, the rate of prostate-specific antigen (PSA) testing remains very low compared with Western countries, and the benefits of population-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitagawa, Yasuhide, Namiki, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430954/
https://www.ncbi.nlm.nih.gov/pubmed/25578935
http://dx.doi.org/10.4103/1008-682X.143756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430954/
https://www.ncbi.nlm.nih.gov/pubmed/25578935
http://dx.doi.org/10.4103/1008-682X.143756

Ejemplares similares